Suicidal ideation and attempts among patients with lifetime physical and/or sexual abuse in treatment for substance use disorders
read more
Citations
ارتباط طرحوارههای غیرانطباقی اولیه یانگ با نیمرخ علامت شناختی scl-90-r
Suicidal ideation and attempts in patients who seek treatment for substance use disorder.
Suicidal attempts among patients with substance use disorders who present with suicidal ideation.
Exploring trajectories of drug use, violence, and suicidality among marginalized women : avenues of intervention and the therapeutic potential of psychedelics
Suicidal behaviors among intravenous drug users: a meta-analysis
References
Statistical Power Analysis for the Behavioral Sciences
Diagnostic and Statistical Manual of Mental Disorders
An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.
Related Papers (5)
Frequently Asked Questions (12)
Q2. What have the authors stated for future works in "Suicidal ideation and attempts among patients with lifetime physical and/or sexual abuse in treatment for substance use disorders running head: drug addiction, lifetime abuse and suicide" ?
Future longitudinal studies should be developed to provide accurate information on the causal link between the variables studied. Future studies should include larger samples to corroborate these results.
Q3. What are the primary symptoms of the SCL-90-R?
The SCL-90-R measures nine areas of primary symptoms: somatisation, obsession-compulsion, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation and psychoticism.
Q4. What was the important factor for determining the prevalence of suicidal thoughts and attempts?
In the bivariate analysisbetween patients with and patients without a history of suicidal ideation and attempts, χ2 or Student’s t test for independent samples was used, depending on the nature of the variables analysed.
Q5. how many people with suicidal ideation have attempted suicide?
The rate of patients with lifetime abuse who presented with suicidal ideation was62.2% (n = 51), with 12.2% of patients presenting with suicidal ideation in the past 30 days (n = 10).
Q6. What is the prevalence of suicidal ideation among patients with addiction problems?
Among patients with drug addiction problems, those presenting with suicidal-related behaviours appear to have suffered more from lifetime abuse.
Q7. What is the main contribution of this study?
another strength of this study is that it explores both the behavioural aspect of suicide (suicide attempts) and the cognitive perspective (suicidal ideation).
Q8. How many subjects did they not complete the two assessment sessions?
Two hundred and ninety-three (78.1%) of the 375 initial subjects did not meetthe above criteria, mainly the third criterion related to lifetime physical and/or sexual abuse (n = 252), followed by 32 patients who did not complete the two assessment sessions, and 9 who did not sign the informed consent.
Q9. How many patients were included in the study?
The initial sample consisted of 375 consecutive patients who sought treatmentfor addiction in one of the two programmes (outpatient and inpatient) of the Proyecto Hombre Navarra Foundation (Spain).
Q10. How many people with substance use problems have attempted suicide?
For suicidal ideation, the prevalence rates range from 17% to 50% (Darvishi, Farhadi, Haghtalab, & Poorolajal, 2015; Garlow, Purselle, & D'Orio, 2003; Moghaddam, Yoon, Dickerson, Kim, & Westermeyer, 2015; Petry & Kiluk, 2002; Vaszari, Bradford, O'Leary, Ben Abdallah, & Cottler, 2011).
Q11. How many subjects were included in the study?
the final sample was composed of 82 subjects [physical abuse: n = 48 (58.5%), sexual abuse: n = 8 (9.8%), and both physical and sexual abuse: n = 26 (31.7%)].
Q12. What was the effect size of the two analyses?
Effect sizes (Cohen’s d) for all of the analyses were provided, taking into account Cohen’s recommendation (Cohen, 1988): d = 0.20 (small effect size), d = 0.50 (medium effect size), and d = 0.80 (large effect size).